Navigation Links
Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico
Date:7/11/2011

costs and expenses; Vanda's inability to obtain the capital necessary to fund additional research and development activities; Vanda's failure to identify or obtain rights to new products or product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; limitations on Vanda's ability to utilize some or all of its prior net operating losses and research and development credits; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products or product candidates under its license and sublicense agreements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2010 which is on file with the SEC and available on the SEC's website at www.sec.gov.  In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
2. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
3. Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
4. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
5. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
6. Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
7. Vanda Pharmaceuticals Files Shelf Registration Statement
8. Vanda Pharmaceuticals Appoints Chief Financial Officer
9. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
10. Vanda Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 3, 2010
11. Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Company plc ("Perrigo") (NYSE: PRGO ; TASE) today ... OTC brands from GSK in an all cash transaction ... demonstration of Perrigo,s unique ability to maximize brand value ... countries.  Perrigo Chairman, President and CEO ... to complete this transaction, which clearly demonstrates our ability ...
(Date:8/28/2015)... , August 28, 2015 The report "Eubiotics ... (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ( ... Asia-Pacific , and Rest of the World) - ... global market for Eubiotics was valued at USD 4.62 Billion ... by 2020, at a CAGR of 7.4% from 2015 to ...
(Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... Nashville, Tenn., Oct. 29 Cumberland ... Pty Ltd., an Australian-based specialty pharmaceutical company, today announced ... commercialization of Caldolor® (ibuprofen) Injection in Australia and New ... to treat pain and fever in the hospital setting. ...
... at Thomas Jefferson University in Philadelphia, PA, supported in part ... Journal of Nuclear Medicine reporting preclinical results of a novel ... [1] . "All tumors detected with the new ... on the plasma membrane of the tumor cells." These results ...
Cached Medicine Technology:Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 2Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 3Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 4Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 5New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors 2New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors 3
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of the stage ... short segment to the subject of diabetes. Diabetes is a debilitating health condition that ... recent advancements in medical science may prove to be a significant breakthrough that sufferers ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number of ... transitioned management companies to partner with Wound Care Advantage (WCA) to utilize the ... , Transitioning wound care management providers can be a complex undertaking. WCA ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce ... the position they are applying for, they are unable to pass the initial drug ... altering drug testing policies in order to be able to hire long-term, skilled talent. ...
Breaking Medicine News(10 mins):Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... Help Plan Members Better Manage Healthcare Needs and Spending , ... Life Insurance Company of America (Guardian), one of the largest ... voluntary benefits for small and mid-sized companies, today introduced enhanced ... their employees will now have access to a broad range ...
... Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical ... novel drugs in the therapeutic areas of infection, oncology ... the first quarter ended March 31, 2009. The ... months ended March 31, 2009 was $2.3 million or ...
... ,Eliminates Complications Including Right Heart Failure , ... ... to INTERMACS data recently published in SynCardia’s 2008 Annual ... a bridge-to-transplant rate of 72% at 6 months. This is ...
... Call to Action demonstrates commitment to combating a leading ... and WaterAid America released two new reports today that ... are not responding to clear evidence on child mortality ... Diarrheal disease, a leading killer of children under age ...
... www.hairfairies.com ) opens new salon to help San Diego,s frantic families ... 12 Hair Fairies, the head lice helpers, ( www.hairfairies.com ) ... lice removal salon in San Diego on May 12, 2009. ... a nationwide, full service salon dedicated to removing head lice. ...
... 12 Miami and NY-based Jeffrey Epstein, M.D., FACS, ... has recently established The Foundation for Hair Restoration and ... surgical hair restoration and plastic surgeons. Recognized for ... will help to position The Foundation for Hair Restoration ...
Cached Medicine News:Health News:Guardian Enhances Medical Plans With New Wellness Benefits 2Health News:Guardian Enhances Medical Plans With New Wellness Benefits 3Health News:Guardian Enhances Medical Plans With New Wellness Benefits 4Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 2Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 3Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 4Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 5Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 6Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 7Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 8Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 9Health News:INTERMACS: Total Artificial Heart Bridge-to-Transplant Rate 2x Higher ,at 6 Months Than BiVADS and LVADs 2Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 2Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 3Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 4Health News:Lice Removal Salon Offers San Diego an Upscale Solution to an Undesirable Problem 2Health News:Foundation for Hair Restoration Brings Breakthrough Surgical Technology to the U.S. and Announces Nationwide Expansion of Its Network of Top Doctors 2
Standard Lipo-tubing...
... Screening, Supplemental Confirmatory (Western Blot): The assay ... antigens on their surface. The cells are ... glass slide. Fixed, uninfected T-cells are provided ... plasma sample with HIV- I antibodies comes ...
Perfect for physicians who prefer a Heavier and Longer tubing, permitting them maximum access around the OR table. 12 feet in length Sizes availabe to fit any vacuum canisters...
Inquire...
Medicine Products: